Effects of Conventional Speech Therapy with Liuzijue Qigong, a Traditional Chinese Method of Breath Training, in 70 Patients with Post-Stroke Spastic Dysarthria
Medical Science Monitor · 2023
DOI: 10.12659/msm.939623 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Medical Science Monitor, 2023. Verfasst von Jiayi Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Service Office, The Second Rehabilitation Hospital of Shanghai, Shanghai, China (mainland). Hauptthemen laut MEDLINE: Qigong, Stroke, Breathing Exercises. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Research Service Office, The Second Rehabilitation Hospital of Shanghai, Shanghai, China (mainland).
- School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China (mainland).
- Department of Rehabilitation, Renhe Hospital of Baoshan District, Shanghai, China (mainland).
Zitieren
APA
Xia, J., Pei, S., Chen, Z., Wang, L., Hu, J., & Wang, J. (2023). Effects of Conventional Speech Therapy with Liuzijue Qigong, a Traditional Chinese Method of Breath Training, in 70 Patients with Post-Stroke Spastic Dysarthria. Medical Science Monitor. https://doi.org/10.12659/msm.939623
Vancouver
Xia J, Pei S, Chen Z, Wang L, Hu J, Wang J. Effects of Conventional Speech Therapy with Liuzijue Qigong, a Traditional Chinese Method of Breath Training, in 70 Patients with Post-Stroke Spastic Dysarthria. Medical Science Monitor. 2023. doi:10.12659/msm.939623
BibTeX
@article{Xia2023,
author = {Xia, Jiayi and Pei, Song and Chen, Zhu and Wang, Lin and Hu, Jun and Wang, Jian},
title = {Effects of Conventional Speech Therapy with Liuzijue Qigong, a Traditional Chinese Method of Breath Training, in 70 Patients with Post-Stroke Spastic Dysarthria},
journal = {Medical Science Monitor},
year = {2023},
doi = {10.12659/msm.939623}
}
EUVIMED